0001909215-22-000001.txt : 20220324 0001909215-22-000001.hdr.sgml : 20220324 20220324151809 ACCESSION NUMBER: 0001909215-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: 4a5 FILED AS OF DATE: 20220324 DATE AS OF CHANGE: 20220324 EFFECTIVENESS DATE: 20220324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avicena North America Inc. CENTRAL INDEX KEY: 0001909215 IRS NUMBER: 874417222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-438794 FILM NUMBER: 22766303 BUSINESS ADDRESS: STREET 1: 209 N PAYNE ST CITY: ALEXANDRIA STATE: VA ZIP: 22314 BUSINESS PHONE: 706-372-2124 MAIL ADDRESS: STREET 1: 209 N PAYNE ST CITY: ALEXANDRIA STATE: VA ZIP: 22314 D 1 primary_doc.xml X0708 D LIVE 0001909215 Avicena North America Inc. 209 N PAYNE ST ALEXANDRIA VA VIRGINIA 22314 706-372-2124 DELAWARE None None Corporation true 2022 Paul Watt 30 Coolgardie St West Perth C3 AUSTRALIA 6005 Director Mr. Watt is a director of the issuer and an officer of the majority shareholder of the issuer Anthony Fitzgerald 30 Coolgardie St West Perth C3 AUSTRALIA 6005 Director Mr. Fitzgerald is a director of the issuer and an officer of the majority shareholder of the issuer William Jackson 215 N Payne St Alexandria VA VIRGINIA L8P 372 Executive Officer Director Mr. Jackson is a director and the interim CFO of the issuer Other Health Care Decline to Disclose 06b 4a5 false 2022-03-22 false true false 1000 44416500 44416500 0 Initial equity financing of the Issuer false 3 0 0 No Finders fees or sales commissions were given for this transaction 0 false Avicena North America Inc. Angus Jackson Angus Jackson Secretary 2022-03-24